Can we navigate the pitfalls of tofacitinib randomized controlled trials in vitiligo? Addressing long-term safety and generalizability for enhanced clinical translation
Fields of Study & Subjects
melanin and skin pigmentation
Mast cells and histamine
Melanoma and MAPK Pathways
Publication details
- Journal / source
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Volume
- 95
- Issue
- 1
- Pages
- e51–e52
- Publication date
- 31 January 2026
- Language
- EN